Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Yamashita Health Care Holdings's 3-Year ROIIC % for the quarter that ended in May. 2026 was 5.06%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Yamashita Health Care Holdings (TSE:9265) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Yamashita Health Care Holdings 3-Year ROIIC % Related Terms
Yamashita Health Care Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings 3-Year ROIIC % Chart
TSE:9265 vs MCK, COR, CAH: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, Yamashita Health Care Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 517.4252 (May. 2026) - 387.9918 (May. 2023) )
/
( 15622 (May. 2026) - 13064 (May. 2023) )
=
129.4334
/
2558
=
5.06%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Yamashita Health Care Holdings (TSE:9265) has a 3-Year ROIIC % of 5.06 as of May. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Yamashita Health Care Holdings and its competitors. This is 62% above median its historical median of 3.12. According to the industry distribution chart, Yamashita Health Care Holdings ranks #47 out of 112 companies in the Medical Distribution industry, placing it in the top 42%.
Is Yamashita Health Care Holdings' 3-Year ROIIC % too high?
Yamashita Health Care Holdings' current 3-Year ROIIC % of 5.06 is 62% above median its 10-year median of 3.12. The Medical Distribution industry median 3-Year ROIIC % is 2.30. Yamashita Health Care Holdings' value of 5.06 is 120.5% above this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #47 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Yamashita Health Care Holdings has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' 3-Year ROIIC % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #47 out of 112 companies for 3-Year ROIIC %. This puts Yamashita Health Care Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 2.30. Yamashita Health Care Holdings' value of 5.06 is 120.5% above this benchmark. While the company's 10-year median is 3.12 vs. the industry median of 2.30, Yamashita Health Care Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.30, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current 3-Year ROIIC % of 5.06 is 120.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current 3-Year ROIIC % is 5.06, which is 62% above median its own 10-year median of 3.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,956.26, compared to a current price of 円3,360.00 — trading 13.7% above its estimated fair value. The current 3-Year ROIIC % is 5.06, which is 62% above median its 10-year median of 3.12 and 120.5% above the Medical Distribution industry median of 2.30. Yamashita Health Care Holdings' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current 3-Year ROIIC % is 5.06 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,360.00 is trading 13.7% above its estimated GF Value™ of 円2,956.26.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
3-Year ROIIC %: 5.06 (62% above median its 10-year median of 3.12)
GF Value™: 円2,956.26 vs. price of 円3,360.00 (13.7% above fair value)
Industry Position: 120.5% above the Medical Distribution median (#47 of 112)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
62GF Score
Get the complete analysis for TSE:9265
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
